{"disease":{"id":"post-viral-fatigue-syndrome","name":"post viral fatigue syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05430152","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Luis Nacul","has_results":false},{"nct_id":"NCT05130736","title":"Rehabilitation Robot in Patients With Post-Coronavirus Disease (COVID-19) Fatigue Syndrome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Poznan University of Medical Sciences","has_results":false},{"nct_id":"NCT04705831","title":"Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"IMMUNOe Research Centers","has_results":false},{"nct_id":"NCT05664711","title":"Effect of Stellate Ganglion Block on ME/CFS","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Neuroversion, Inc.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}